The Wall Street Journal, March 9, 2016. Patient-safety advocates, including the National Center for Health Research, warn that the bills would weaken the FDA’s ability to ensure devices’ safety.
Read More »News That Quotes Us & Our Work
We are often quoted in major newspapers and magazines, and on well-respected TV shows, radio programs, and websites where we share our opinion on issues that matter to you and your health. Stay up to date on health news and our take on it by reading the articles in this section.
Senate HELP Innovate-A-Palooza
Politico, March 9, 2016. The National Center for Health Research is concerned that the Innovation Act, including the MEDTECH bill, will endanger patient safety by reducing FDA oversight.
Read More »PhRMA: Easing Speech Limits Could Reduce Need for Subgroups in Trials
InsideHealthPolicy.com, March 7, 2016. While minority, patient and consumer groups pushed for more diversity in the clinical trial phase, Jocelyn Ulrich director of scientific and regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), said matching demographic subgroups based on sex, age and race, specifically the African American and Hispanic populations, to disease prevalence would extend phase III clinical trials by 20 months or longer.
Read More »Remedy for a Sick Industry
Portland Tribune, March 3, 2016. If he were playing it safe, Dr. Vinay Prasad might be among the last to turn into a medical provocateur. Prasad’s outspokenness and willingness to criticize industrywide assumptions place him in the ranks of a small but influential group of physicians and researchers who are either having an impact on the way medicine is practiced in the United States, or tilting at windmills.
Read More »Olympus Settles Largest Kickback Lawsuit for a Medical Device Company in U.S. History
Plastics Today, March 2, 2016. Companies that put profit before consumer safety must be reprimanded, including Olympus Corp. for their infection spreading duodenoscopes.
Read More »